These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34099306)

  • 1. Biologics for the Treatment of Recurrent Respiratory Papillomatosis.
    Allen CT
    Otolaryngol Clin North Am; 2021 Aug; 54(4):769-777. PubMed ID: 34099306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
    Jackowska J; Piersiala K; Klimza H; Wierzbicka M
    Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update.
    Donne AJ; Kinshuck A
    Expert Opin Pharmacother; 2021 Oct; 22(14):1901-1908. PubMed ID: 34080517
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
    Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases.
    Bedoya A; Glisinski K; Clarke J; Lind RN; Buckley CE; Shofer S
    Am J Case Rep; 2017 Jul; 18():842-846. PubMed ID: 28757601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
    Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
    Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic bevacizumab for end-stage juvenile recurrent respiratory papillomas: A case report.
    Hamdi O; Dome J; Zalzal G; Preciado D
    Int J Pediatr Otorhinolaryngol; 2020 Jan; 128():109706. PubMed ID: 31610441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
    Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
    Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
    Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
    Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
    Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
    J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
    Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
    Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
    So RJ; Rayle C; Joo HH; Huang EY; Seiwert TY; Raabe EH; Best SR
    Laryngoscope; 2024 Jul; 134(7):3253-3259. PubMed ID: 38525973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic bevacizumab for recurrent respiratory papillomatosis.
    Baday YI; Ongkasuwan J; Venkatramani R
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110352. PubMed ID: 32906078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
    Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis.
    Robbins Y; Friedman J; Clavijo PE; Sievers C; Bai K; Donahue RN; Schlom J; Sinkoe A; Hinrichs CS; Allen C; Abdul Sater H; Gulley JL; Norberg S
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
    Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
    Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.
    Evers G; Schliemann C; Beule A; Schmidt LH; Schulze AB; Kessler C; Hoffmann TK; Wiewrodt R; Groll AH; Bleckmann A; Rudack C; Berdel WE; Mohr M
    Laryngoscope; 2021 Jun; 131(6):E1926-E1933. PubMed ID: 33382105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive recurrent respiratory papillomatosis: A series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experience.
    Collette F; Lawson G; Hassid S; Delahaut G; Bachy V; Van Der Vorst S; Faugeras L; Gilliaux Q; D'Hondt L
    Head Neck; 2023 May; 45(5):1071-1079. PubMed ID: 36840929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery and Adjuvant Therapy Improve Derkay Scores in Adult and Pediatric Respiratory Papillomatosis.
    Hock K; Kennedy A; Howell R; Friedman A; de Alarcon A; Khosla S
    Laryngoscope; 2022 Dec; 132(12):2420-2426. PubMed ID: 35119691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review.
    Pogoda L; Ziylan F; Smeeing DPJ; Dikkers FG; Rinkel RNPM
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4229-4240. PubMed ID: 35462578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.